Search

Your search keyword '"Gavin, Patrick G."' showing total 130 results
Start Over Author "Gavin, Patrick G."
130 results on '"Gavin, Patrick G."'

3. Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials

Author

Baker, Tina, primary, Sharifian, Hoda, additional, Newcombe, Paul J, additional, Gavin, Patrick G, additional, Lazarus, Mark N, additional, Ramaswamy, Madhu, additional, White, Wendy I, additional, Ferrari, Nicola, additional, Muthas, Daniel, additional, Tummala, Raj, additional, Morand, Eric F, additional, Furie, Richard, additional, Vital, Edward M, additional, Chamberlain, Chris, additional, Platt, Adam, additional, Al-Mossawi, Hussein, additional, Brohawn, Philip Z, additional, and Csomor, Eszter, additional

Published
2024
Full Text
View/download PDF

4. Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer

Author

Chen, Lujia, primary, Wang, Ying, additional, Cai, Chunhui, additional, Ding, Ying, additional, Kim, Rim S., additional, Lipchik, Corey, additional, Gavin, Patrick G., additional, Yothers, Greg, additional, Allegra, Carmen J., additional, Petrelli, Nicholas J., additional, Suga, Jennifer Marie, additional, Hopkins, Judith O., additional, Saito, Naoyuki G., additional, Evans, Terry, additional, Jujjavarapu, Srinivas, additional, Wolmark, Norman, additional, Lucas, Peter C., additional, Paik, Soonmyung, additional, Sun, Min, additional, Pogue-Geile, Katherine L., additional, and Lu, Xinghua, additional

Published
2024
Full Text
View/download PDF

6. Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

Author

Jacobs, Samuel A., Robidoux, André, Abraham, Jame, Pérez-Garcia, José Manuel, La Verde, Nicla, Orcutt, James M., Cazzaniga, Marina E., Piette, Fanny, Antolín, Silvia, Aguirre, Elena, Cortes, Javier, Llombart-Cussac, Antonio, Di Cosimo, Serena, Kim, Rim S., Feng, Huichen, Lipchik, Corey, Lucas, Peter C., Srinivasan, Ashok, Wang, Ying, Song, Nan, Gavin, Patrick G., Balousek, April D., Paik, Soonmyung, Allegra, Carmen J., Wolmark, Norman, and Pogue-Geile, Katherine L.

Published
2020
Full Text
View/download PDF

8. NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

Author

Jacobs, Samuel A., Robidoux, André, Abraham, Jame, Pérez-Garcia, José Manuel, La Verde, Nicla, Orcutt, James M., Cazzaniga, Marina E., Piette, Fanny, Antolín, Silvia, Aguirre, Elena, Cortes, Javier, Llombart-Cussac, Antonio, Di Cosimo, Serena, Kim, Rim S., Feng, Huichen, Lipchik, Corey, Lucas, Peter C., Srinivasan, Ashok, Wang, Ying, Song, Nan, Gavin, Patrick G., Balousek, April D., Paik, Soonmyung, Allegra, Carmen J., Wolmark, Norman, and Pogue-Geile, Katherine L.

Published
2019
Full Text
View/download PDF

9. Figure S2 from Neratinib-Plus-Cetuximab in Quadruple-WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study

Author

Jacobs, Samuel A., primary, Lee, James J., primary, George, Thomas J., primary, Wade, James L., primary, Stella, Philip J., primary, Wang, Ding, primary, Sama, Ashwin R., primary, Piette, Fanny, primary, Pogue-Geile, Katherine L., primary, Kim, Rim S., primary, Gavin, Patrick G., primary, Lipchik, Corey, primary, Feng, Huichen, primary, Wang, Ying, primary, Finnigan, Melanie, primary, Kiesel, Brian F., primary, Beumer, Jan H., primary, Wolmark, Norman, primary, Lucas, Peter C., primary, Allegra, Carmen J., primary, and Srinivasan, Ashok, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Data from Neratinib-Plus-Cetuximab in Quadruple-WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study

Author

Jacobs, Samuel A., primary, Lee, James J., primary, George, Thomas J., primary, Wade, James L., primary, Stella, Philip J., primary, Wang, Ding, primary, Sama, Ashwin R., primary, Piette, Fanny, primary, Pogue-Geile, Katherine L., primary, Kim, Rim S., primary, Gavin, Patrick G., primary, Lipchik, Corey, primary, Feng, Huichen, primary, Wang, Ying, primary, Finnigan, Melanie, primary, Kiesel, Brian F., primary, Beumer, Jan H., primary, Wolmark, Norman, primary, Lucas, Peter C., primary, Allegra, Carmen J., primary, and Srinivasan, Ashok, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table 3 from Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value

Author

Gavin, Patrick G., primary, Colangelo, Linda H., primary, Fumagalli, Debora, primary, Tanaka, Noriko, primary, Remillard, Matthew Y., primary, Yothers, Greg, primary, Kim, Chungyeul, primary, Taniyama, Yusuke, primary, Kim, Seung Il, primary, Choi, Hyun Joo, primary, Blackmon, Nicole L., primary, Lipchik, Corey, primary, Petrelli, Nicholas J., primary, O'Connell, Michael J., primary, Wolmark, Norman, primary, Paik, Soonmyung, primary, and Pogue-Geile, Kay L., primary

Published
2023
Full Text
View/download PDF

12. Supplementary Table 1 from Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value

Author

Gavin, Patrick G., primary, Colangelo, Linda H., primary, Fumagalli, Debora, primary, Tanaka, Noriko, primary, Remillard, Matthew Y., primary, Yothers, Greg, primary, Kim, Chungyeul, primary, Taniyama, Yusuke, primary, Kim, Seung Il, primary, Choi, Hyun Joo, primary, Blackmon, Nicole L., primary, Lipchik, Corey, primary, Petrelli, Nicholas J., primary, O'Connell, Michael J., primary, Wolmark, Norman, primary, Paik, Soonmyung, primary, and Pogue-Geile, Kay L., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table 2 from Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value

Author

Gavin, Patrick G., primary, Colangelo, Linda H., primary, Fumagalli, Debora, primary, Tanaka, Noriko, primary, Remillard, Matthew Y., primary, Yothers, Greg, primary, Kim, Chungyeul, primary, Taniyama, Yusuke, primary, Kim, Seung Il, primary, Choi, Hyun Joo, primary, Blackmon, Nicole L., primary, Lipchik, Corey, primary, Petrelli, Nicholas J., primary, O'Connell, Michael J., primary, Wolmark, Norman, primary, Paik, Soonmyung, primary, and Pogue-Geile, Kay L., primary

Published
2023
Full Text
View/download PDF

14. Additional file 1 of Multi-omic interactions in the gut of children at the onset of islet autoimmunity

Author

Gavin, Patrick G., Kim, Ki Wook, Craig, Maria E., Hill, Michelle M., and Hamilton-Williams, Emma E.

Abstract

Additional file 1: Supplementary Figure S1. The number of OTUs observed is correlated to the number of nonhuman proteins detected. Each color represents a subject, and the lines indicate repeated measures for representative individuals. Correlation (R=0.83) was determined for repeated measures (p0.1). Supplementary Figure S5. Microbial functions associated with mastadenovirus. Proteins were aggregated by their Cluster of Orthologous Group (COG) assignments and evaluated for association with viral infection. Summed protein intensity from nine COGs shown are associated with the presence of mastadenovirus (q1 to any factor. (B) The association of the latent factors with other variables. Q-values from a linear mixed model adjusted for age.

Published
2023
Full Text
View/download PDF

17. Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2–Positive Breast Cancer: Analysis of the NSABP B-31 Trial

Author

Gavin, Patrick G., Song, Nan, Kim, S. Rim, Lipchik, Corey, Johnson, Nicole L., Bandos, Hanna, Finnigan, Melanie, Rastogi, Priya, Fehrenbacher, Louis, Mamounas, Eleftherios P., Swain, Sandra M., Wickerham, D. Lawrence, Geyer, Charles E., Jr, Jeong, Jong-Hyeon, Costantino, Joseph P., Wolmark, Norman, Paik, Soonmyung, and Pogue-Geile, Kay L.

Published
2017
Full Text
View/download PDF

19. Association of multiplex-immunofluorescence (m-IF) and gene expression signature with prognosis and bevacizumab (bev) treatment outcomes in NRG oncology/NSABP C-08: Implications for combining immune checkpoint blockade (ICB) and bev.

Author

Pogue-Geile, Katherine L., primary, Joy, Marion E, additional, Wang, Ying, additional, Kim, Rim S, additional, Gavin, Patrick G, additional, Fumagalli, Debora, additional, Yothers, Greg, additional, Allegra, Carmen Joseph, additional, Srinivasan, Ashok, additional, Finnigan, Melanie, additional, Jacobs, Samuel A., additional, George, Thomas J., additional, Suga, Jennifer Marie, additional, Hopkins, Judith O., additional, Saito, Naoyuki G., additional, Wolmark, Norman, additional, Paik, Soonmyung, additional, and Lucas, Peter C., additional

Published
2022
Full Text
View/download PDF

20. Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31

Author

Pogue-Geile, Katherine L., Kim, Chungyeul, Jeong, Jong-Hyeon, Tanaka, Noriko, Bandos, Hanna, Gavin, Patrick G., Fumagalli, Debora, Goldstein, Lynn C., Sneige, Nour, Burandt, Eike, Taniyama, Yusuke, Bohn, Olga L., Lee, Ahwon, Kim, Seung-Il, Reilly, Megan L., Remillard, Matthew Y., Blackmon, Nicole L., Kim, Seong-Rim, Horne, Zachary D., Rastogi, Priya, Fehrenbacher, Louis, Romond, Edward H., Swain, Sandra M., Mamounas, Eleftherios P., Wickerham, D. Lawrence, Geyer, Charles E., Jr, Costantino, Joseph P., Wolmark, Norman, and Paik, Soonmyung

Published
2013
Full Text
View/download PDF

21. An acetate‐yielding diet imprints an immune and anti‐microbial programme against enteric infection

Author

Yap, Yu Anne, primary, McLeod, Keiran H, additional, McKenzie, Craig I, additional, Gavin, Patrick G, additional, Davalos‐Salas, Mercedes, additional, Richards, James L, additional, Moore, Robert J, additional, Lockett, Trevor J, additional, Clarke, Julie M, additional, Eng, Vik Ven, additional, Pearson, Jaclyn S, additional, Hamilton‐Williams, Emma E, additional, Mackay, Charles R, additional, and Mariño, Eliana, additional

Published
2021
Full Text
View/download PDF

22. Neratinib-Plus-Cetuximab in Quadruple-WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study

Author

Jacobs, Samuel A., primary, Lee, James J., additional, George, Thomas J., additional, Wade, James L., additional, Stella, Philip J., additional, Wang, Ding, additional, Sama, Ashwin R., additional, Piette, Fanny, additional, Pogue-Geile, Katherine L., additional, Kim, Rim S., additional, Gavin, Patrick G., additional, Lipchik, Corey, additional, Feng, Huichen, additional, Wang, Ying, additional, Finnigan, Melanie, additional, Kiesel, Brian F., additional, Beumer, Jan H., additional, Wolmark, Norman, additional, Lucas, Peter C., additional, Allegra, Carmen J., additional, and Srinivasan, Ashok, additional

Published
2020
Full Text
View/download PDF

23. Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831

Author

Pogue-Geile, Katherine L, primary, Song, Nan, additional, Serie, Daniel J, additional, Wang, Ying, additional, Gavin, Patrick G, additional, Kim, Rim S, additional, Tanaka, Noriko, additional, Fumagalli, Debora, additional, Taniyama, Yusuke, additional, Li, Zhuo, additional, Rastogi, Priya, additional, Swain, Sandra M, additional, Mamounas, Eleftherios P, additional, Geyer, Charles E, additional, Wolmark, Norman, additional, Lucas, Peter C, additional, Paik, Soonmyung, additional, and Thompson, E Aubrey, additional

Published
2020
Full Text
View/download PDF

24. Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

Author

Jacobs, S, Robidoux, A, Abraham, J, Pérez-Garcia, J, La Verde, N, Orcutt, J, Cazzaniga, M, Piette, F, Antolín, S, Aguirre, E, Cortes, J, Llombart-Cussac, A, Di Cosimo, S, Kim, R, Feng, H, Lipchik, C, Lucas, P, Srinivasan, A, Wang, Y, Song, N, Gavin, P, Balousek, A, Paik, S, Allegra, C, Wolmark, N, Pogue-Geile, K, Jacobs, Samuel A, Robidoux, André, Abraham, Jame, Pérez-Garcia, José Manuel, La Verde, Nicla, Orcutt, James M, Cazzaniga, Marina E, Piette, Fanny, Antolín, Silvia, Aguirre, Elena, Cortes, Javier, Llombart-Cussac, Antonio, Di Cosimo, Serena, Kim, Rim S, Feng, Huichen, Lipchik, Corey, Lucas, Peter C, Srinivasan, Ashok, Wang, Ying, Song, Nan, Gavin, Patrick G, Balousek, April D, Paik, Soonmyung, Allegra, Carmen J, Wolmark, Norman, Pogue-Geile, Katherine L, Jacobs, S, Robidoux, A, Abraham, J, Pérez-Garcia, J, La Verde, N, Orcutt, J, Cazzaniga, M, Piette, F, Antolín, S, Aguirre, E, Cortes, J, Llombart-Cussac, A, Di Cosimo, S, Kim, R, Feng, H, Lipchik, C, Lucas, P, Srinivasan, A, Wang, Y, Song, N, Gavin, P, Balousek, A, Paik, S, Allegra, C, Wolmark, N, Pogue-Geile, K, Jacobs, Samuel A, Robidoux, André, Abraham, Jame, Pérez-Garcia, José Manuel, La Verde, Nicla, Orcutt, James M, Cazzaniga, Marina E, Piette, Fanny, Antolín, Silvia, Aguirre, Elena, Cortes, Javier, Llombart-Cussac, Antonio, Di Cosimo, Serena, Kim, Rim S, Feng, Huichen, Lipchik, Corey, Lucas, Peter C, Srinivasan, Ashok, Wang, Ying, Song, Nan, Gavin, Patrick G, Balousek, April D, Paik, Soonmyung, Allegra, Carmen J, Wolmark, Norman, and Pogue-Geile, Katherine L

Abstract

After the publication [1] the authors report corrections for Table 3, for the headers of columns 5 and 7, which should read as follows: Column 5 Header: P-value for pCR, T vs Other Arms in HR+, and Column 7 Header: P-value for pCR, T vs Other Arms in HR-. The correct version of the table can be found below. (Table presented).

Published
2020

25. Correction: NSABP FB-7: A phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer (Breast Cancer Research (2019) 21 (133) DOI: 10.1186/s13058-019-1196-y)

Author

Jacobs, Samuel A, Jacobs, S, Robidoux, A, Abraham, J, Pérez-Garcia, J, La Verde, N, Orcutt, J, Cazzaniga, M, Piette, F, Antolín, S, Aguirre, E, Cortes, J, Llombart-Cussac, A, Di Cosimo, S, Kim, R, Feng, H, Lipchik, C, Lucas, P, Srinivasan, A, Wang, Y, Song, N, Gavin, P, Balousek, A, Paik, S, Allegra, C, Wolmark, N, Pogue-Geile, K, Jacobs, Samuel A, Robidoux, André, Abraham, Jame, Pérez-Garcia, José Manuel, La Verde, Nicla, Orcutt, James M, Cazzaniga, Marina E, Piette, Fanny, Antolín, Silvia, Aguirre, Elena, Cortes, Javier, Llombart-Cussac, Antonio, Di Cosimo, Serena, Kim, Rim S, Feng, Huichen, Lipchik, Corey, Lucas, Peter C, Srinivasan, Ashok, Wang, Ying, Song, Nan, Gavin, Patrick G, Balousek, April D, Paik, Soonmyung, Allegra, Carmen J, Wolmark, Norman, Pogue-Geile, Katherine L, Jacobs, Samuel A, Jacobs, S, Robidoux, A, Abraham, J, Pérez-Garcia, J, La Verde, N, Orcutt, J, Cazzaniga, M, Piette, F, Antolín, S, Aguirre, E, Cortes, J, Llombart-Cussac, A, Di Cosimo, S, Kim, R, Feng, H, Lipchik, C, Lucas, P, Srinivasan, A, Wang, Y, Song, N, Gavin, P, Balousek, A, Paik, S, Allegra, C, Wolmark, N, Pogue-Geile, K, Jacobs, Samuel A, Robidoux, André, Abraham, Jame, Pérez-Garcia, José Manuel, La Verde, Nicla, Orcutt, James M, Cazzaniga, Marina E, Piette, Fanny, Antolín, Silvia, Aguirre, Elena, Cortes, Javier, Llombart-Cussac, Antonio, Di Cosimo, Serena, Kim, Rim S, Feng, Huichen, Lipchik, Corey, Lucas, Peter C, Srinivasan, Ashok, Wang, Ying, Song, Nan, Gavin, Patrick G, Balousek, April D, Paik, Soonmyung, Allegra, Carmen J, Wolmark, Norman, and Pogue-Geile, Katherine L

Abstract

After the publication [1] the authors report corrections for Table 3, for the headers of columns 5 and 7, which should read as follows: Column 5 Header: P-value for pCR, T vs Other Arms in HR+, and Column 7 Header: P-value for pCR, T vs Other Arms in HR-. The correct version of the table can be found below. (Table presented).

Published
2020

26. Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31

Author

Chumsri, Saranya, primary, Li, Zhuo, additional, Serie, Daniel J., additional, Mashadi-Hossein, Afshin, additional, Colon-Otero, Gerardo, additional, Song, Nan, additional, Pogue-Geile, Katherine L., additional, Gavin, Patrick G., additional, Paik, Soonmyung, additional, Moreno-Aspitia, Alvaro, additional, Perez, Edith A., additional, and Thompson, E. Aubrey, additional

Published
2019
Full Text
View/download PDF

27. Abstract 3407: Development of a chemokine signature identifying dMMR patients (pts) with poor prognosis

Author

Wang, Ying, primary, Kim, Rim S., additional, Lipchik, Corey, additional, Srinivasan, Ashok, additional, Feng, Huichen, additional, Song, Nan, additional, Allegra, Carmen J., additional, Gavin, Patrick G., additional, Jacobs, Samuel A., additional, Wolmark, Norman, additional, Lucas, Peter C., additional, and Pogue-Geile, Katherine L., additional

Published
2019
Full Text
View/download PDF

29. Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer

Author

Kim, Rim S, primary, Song, Nan, additional, Gavin, Patrick G, additional, Salgado, Roberto, additional, Bandos, Hanna, additional, Kos, Zuzana, additional, Floris, Giuseppe, additional, Eynden, Gert G G M Van den, additional, Badve, Sunil, additional, Demaria, Sandra, additional, Rastogi, Priya, additional, Fehrenbacher, Louis, additional, Mamounas, Eleftherios P, additional, Swain, Sandra M, additional, Wickerham, D Lawrence, additional, Costantino, Joseph P, additional, Paik, Soonmyung, additional, Wolmark, Norman, additional, Geyer, Charles E, additional, Lucas, Peter C, additional, and Pogue-Geile, Katherine L, additional

Published
2019
Full Text
View/download PDF

30. A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes

Author

Paik Soonmyung, Choi Hyun-Joo, Kim Seung-Il, Taniyama Yusuke, Gavin Patrick G, Fumagalli Debora, and Pogue-Geile Katherine L

Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Background An increasing number of studies show that genetic markers can aid in refining prognostic information and predicting the benefit from systemic therapy. Our goal was to develop a high throughput, cost-effective and simple methodology for the detection of clinically relevant hot spot mutations in colon cancer. Methods The Maldi-Tof mass spectrometry platform and OncoCarta panel from Sequenom were used to profile 239 colon cancers and 39 metastatic lymph nodes from NSABP clinical trial C-07 utilizing routinely processed FFPET (formalin-fixed paraffin-embedded tissue). Results Among the 238 common hot-spot cancer mutations in 19 genes interrogated by the OncoCarta panel, mutations were detected in 7 different genes at 26 different nucleotide positions in our colon cancer samples. Twenty-four assays that detected mutations in more than 1% of the samples were reconfigured into a new multiplexed panel, termed here as ColoCarta. Mutation profiling was repeated on 32 mutant samples using ColoCarta and the results were identical to results with OncoCarta, demonstrating that this methodology was reproducible. Further evidence demonstrating the validity of the data was the fact that the mutation frequencies of the most common colon cancer mutations were similar to the COSMIC (Catalog of Somatic Mutations in Cancer) database. The frequencies were 43.5% for KRAS, 20.1% for PIK3CA, and 12.1% for BRAF. In addition, infrequent mutations in NRAS, AKT1, ABL1, and MET were detected. Mutation profiling of metastatic lymph nodes and their corresponding primary tumors showed that they were 89.7% concordant. All mutations found in the lymph nodes were also found in the corresponding primary tumors, but in 4 cases a mutation was present in the primary tumor only. Conclusions This study describes a high throughput technology that can be used to interrogate DNAs isolated from routinely processed FFPET and identifies the specific mutations that are common to colon cancer. The development of this technology and the ColoCarta panel may provide a mechanism for rapid screening of mutations in clinically relevant genes like KRAS, PIK3CA, and BRAF. Trial Registration ClinicalTrials.gov: NSABP C-07: NCT00004931

Published
2010
Full Text
View/download PDF

31. Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations

Author

Pal, Rekha, primary, Wei, Ning, additional, Song, Nan, additional, Wu, Shaoyu, additional, Kim, Rim S., additional, Wang, Ying, additional, Gavin, Patrick G., additional, Lucas, Peter C., additional, Srinivasan, Ashok, additional, Allegra, Carmen J., additional, Jacobs, Samuel A., additional, Paik, Soonmyung, additional, Schmitz, John C., additional, and Pogue-Geile, Katherine L., additional

Published
2018
Full Text
View/download PDF

33. NRG Oncology/NSABP B-31: Stromal tumor infiltrating lymphocytes (sTILs) and outcomes in early-stage HER2-positive breast cancer (BC).

Author

Kim, Rim S., primary, Song, Nan, additional, Gavin, Patrick G., additional, Salgado, Roberto, additional, Bandos, Hanna, additional, Kos, Zuzana, additional, Floris, Giuseppe, additional, Van den Eynden, Gert G., additional, Badve, Sunil S., additional, Rastogi, Priya, additional, Fehrenbacher, Louis, additional, Mamounas, Eleftherios P., additional, Swain, Sandra M., additional, Wickerham, Donald Lawrence, additional, Lucas, Peter C., additional, Costantino, Joseph P., additional, Geyer, Charles E., additional, Wolmark, Norman, additional, Paik, Soonmyung, additional, and Pogue-Geile, Katherine L., additional

Published
2018
Full Text
View/download PDF

35. Abstract 5167: Stem-like colorectal cancer cell lines show response to the ERK1/2 inhibitor, SCH772984, alone and in combination with neratinib

Author

Pal, Rekha, primary, Wei, Ning, additional, Song, Nan, additional, Wu, Shao-yu, additional, Kim, S. Rim, additional, Gavin, Patrick G., additional, Lucas, Peter C., additional, Srinivasan, Ashok, additional, Jacobs, Samuel A., additional, Paik, Soonmyung, additional, Schmitz, John C., additional, and Pogue-Geile, Kay, additional

Published
2017
Full Text
View/download PDF

36. Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes

Author

Song, Nan, primary, Pogue-Geile, Katherine L., additional, Gavin, Patrick G., additional, Yothers, Greg, additional, Kim, S. Rim, additional, Johnson, Nicole L., additional, Lipchik, Corey, additional, Allegra, Carmen J., additional, Petrelli, Nicholas J., additional, O’Connell, Michael J., additional, Wolmark, Norman, additional, and Paik, Soonmyung, additional

Published
2016
Full Text
View/download PDF

37. Clinical outcome and benefit of oxaliplatin in colon cancer according to intrinsic subtypes: Results from NRG Oncology/NSABP C-07.

Author

Pogue-Geile, Kay L., primary, Song, Nan, additional, Gavin, Patrick G., additional, Yothers, Greg, additional, Kim, S. Rim, additional, Johnson, Nicole L., additional, Lipchik, Corey, additional, Allegra, Carmen Joseph, additional, Petrelli, Nicholas J., additional, O'Connell, Michael J., additional, Wolmark, Norman, additional, and Paik, Soonmyung, additional

Published
2016
Full Text
View/download PDF

39. Abstract 2837: A surrogate gene expression signature of tumor infiltrating lymphocytes (TILs) predicts degree of benefit from trastuzumab added to standard adjuvant chemotherapy in NSABP (NRG) trial B-31 for HER2+ breast cancer

Author

Kim, Seong-Rim, primary, Gavin, Patrick G., additional, Pogue-Geile, Katherine L., additional, Song, Nan, additional, Finnigan, Melanie, additional, Bandos, Hanna, additional, Jeong, Jong-Hyeon, additional, Rastogi, Priya, additional, Romond, Edward H., additional, Fehrenbacher, Louis, additional, Mamounas, Eleftherios P., additional, Swain, Sandra M., additional, Wickerham, D. Lawrence, additional, Geyer, Charles E., additional, Costantino, Joseph P., additional, and Wolmark, Norman, additional

Published
2015
Full Text
View/download PDF

40. Abstract CT129: Association of the FCGR2A and FCGR3A genotypes with trastuzumab benefit in NSABP B-31

Author

Gavin, Patrick G., primary, Song, Nan, additional, Johnson, Nicole L., additional, Lipchik, Corey, additional, Kim, Seong-Rim, additional, Finnigan, Melanie, additional, Bandos, Hanna, additional, Jeong, Jong-Hyeon, additional, Costantino, Joseph P., additional, Rastogi, Priya, additional, Romond, Edward H., additional, Fehrenbacher, Louis, additional, Mamounas, Eleftherios P., additional, Swain, Sandra M., additional, Wickerham, D. Lawrence, additional, Geyer, Charles E., additional, Wolmark, Norman, additional, Paik, Soonmyung, additional, and Pogue-Geile, Katherine L., additional

Published
2015
Full Text
View/download PDF

42. Intrinsic Subtypes, PIK3CA Mutation, and the Degree of Benefit From Adjuvant Trastuzumab in the NSABP B-31 Trial

Author

Pogue-Geile, Katherine L., primary, Song, Nan, additional, Jeong, Jong-Hyeon, additional, Gavin, Patrick G., additional, Kim, Seong-Rim, additional, Blackmon, Nicole L., additional, Finnigan, Melanie, additional, Rastogi, Priya, additional, Fehrenbacher, Louis, additional, Mamounas, Eleftherios P., additional, Swain, Sandra M., additional, Wickerham, D. Lawrence, additional, Geyer, Charles E., additional, Costantino, Joseph P., additional, Wolmark, Norman, additional, and Paik, Soonmyung, additional

Published
2015
Full Text
View/download PDF

43. Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value.

Author

Gavin, Patrick G, Colangelo, Linda H, Fumagalli, Debora, Tanaka, Noriko, Remillard, Matthew Y, Yothers, Greg, Kim, Chungyeul, Taniyama, Yusuke, Kim, Seung Il, Choi, Hyun Joo, Blackmon, Nicole L, Lipchik, Corey, Petrelli, Nicholas J, O'Connell, Michael J, Wolmark, Norman, Paik, Soonmyung, Pogue-Geile, Kay L, Gavin, Patrick G, Colangelo, Linda H, Fumagalli, Debora, Tanaka, Noriko, Remillard, Matthew Y, Yothers, Greg, Kim, Chungyeul, Taniyama, Yusuke, Kim, Seung Il, Choi, Hyun Joo, Blackmon, Nicole L, Lipchik, Corey, Petrelli, Nicholas J, O'Connell, Michael J, Wolmark, Norman, Paik, Soonmyung, and Pogue-Geile, Kay L

Abstract

The purpose of this study was to examine the prognostic and oxaliplatin predictive value of mismatch repair (MMR) status and common hot spot mutations, which we previously identified in stage II and III colon cancer., Journal Article, Research Support, N.I.H. Extramural, Research Support, Non-U.S. Gov't, info:eu-repo/semantics/published

Published
2012

44. A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes.

Author

Fumagalli, Debora, Gavin, Patrick G, Taniyama, Yusuke, Kim, Seung Il, Choi, Hyun Joo, Paik, Soonmyung, Pogue-Geile, Katherine L, Fumagalli, Debora, Gavin, Patrick G, Taniyama, Yusuke, Kim, Seung Il, Choi, Hyun Joo, Paik, Soonmyung, and Pogue-Geile, Katherine L

Abstract

An increasing number of studies show that genetic markers can aid in refining prognostic information and predicting the benefit from systemic therapy. Our goal was to develop a high throughput, cost-effective and simple methodology for the detection of clinically relevant hot spot mutations in colon cancer., Journal Article, Research Support, N.I.H. Extramural, Research Support, Non-U.S. Gov't, info:eu-repo/semantics/published

Published
2010

47. Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value

Author

Gavin, Patrick G., primary, Colangelo, Linda H., additional, Fumagalli, Debora, additional, Tanaka, Noriko, additional, Remillard, Matthew Y., additional, Yothers, Greg, additional, Kim, Chungyeul, additional, Taniyama, Yusuke, additional, Kim, Seung Il, additional, Choi, Hyun Joo, additional, Blackmon, Nicole L., additional, Lipchik, Corey, additional, Petrelli, Nicholas J., additional, O'Connell, Michael J., additional, Wolmark, Norman, additional, Paik, Soonmyung, additional, and Pogue-Geile, Kay L., additional

Published
2012
Full Text
View/download PDF

50. Abstract A201: Mutation profiling and prognostic value of BRAF, HRAS, KRAS, MET, NRAS, PIK3CA, KRASG12V in colon cancer: Results from NSABP C‐07

Author

Pogue‐Geile, Kay L., primary, Fumagalli, Debora, additional, Gavin, Patrick G., additional, Colangelo, Linda, additional, Taniyama, Yusuke, additional, Kim, Seung‐Il, additional, Choi, Hyun‐Joo, additional, Kim, Chung, additional, Kuebler, J. Philip, additional, Geyer, Charles E., additional, Petrelli, Nick, additional, O'Connell, Michael J., additional, Yothers, Greg, additional, Paik, Soonmyung, additional, and Wolmark, Norman, additional

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results